SHINE Technologies, LLC, a next-generation fusion technology company, announced that Harrie Buurlage has been named Chief Commercial Officer of Isotopes. Buurlage, who has been the General Manager of SHINE Europe since 2019, will now oversee all commercial aspects of SHINE’s therapeutic and diagnostic medical isotope divisions. Supporting Buurlage in driving the growth of SHINE’s medical…